The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 2,596 | 100,600 | SH | SOLE | 100,600 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,933 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AFFIMED NV | COM | N01045108 | 7,951 | 590,300 | SH | SOLE | 590,300 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 472 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 13,121 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
AMARIN CORP PLC | COM | 023111206 | 4,315 | 1,754,000 | SH | SOLE | 1,754,000 | 0 | 0 | ||
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 12,405 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
AURIS MED HLDG AG | COM | H03579101 | 1,725 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
AVINGER INC | COM | 053734109 | 2,688 | 208,200 | SH | SOLE | 208,200 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 6,657 | 2,120,000 | SH | SOLE | 2,120,000 | 0 | 0 | ||
BIOLINERX LTD | COM | 09071M106 | 495 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 4,131 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
CELGENE CORP | RIGHTS | 151020112 | 950 | 456,492 | SH | SOLE | 456,492 | 0 | 0 | ||
CEMPRA INC | COM | 15130J109 | 16,836 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 20,328 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 7,909 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 6,706 | 1,724,000 | SH | SOLE | 1,724,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 330 | 18,800 | SH | SOLE | 18,800 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 4,043 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
EVOKE PHARMA INC | COM | 30049G104 | 1,355 | 259,100 | SH | SOLE | 259,100 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 7,638 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
FLAMEL TECHNOLOGIES SA | COM | 338488109 | 6,569 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | COM | M46135105 | 871 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 7,811 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
IMPRIMIS PHARMACEUTICALS INC | COM | 45323A201 | 9,797 | 1,205,000 | SH | SOLE | 1,205,000 | 0 | 0 | ||
INNOCOLL AG | COM | 45780Q103 | 1,481 | 101,200 | SH | SOLE | 101,200 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780VAA0 | 2,963 | 604,700 | SH | SOLE | 604,700 | 0 | 0 | ||
INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 3,197 | 89,000 | SH | SOLE | 89,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 3,417 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
MEDGENICS INC | COM NEW | 58436Q203 | 6,437 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
MIMEDX GROUP INC | COM | 602496101 | 7,151 | 617,000 | SH | SOLE | 617,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 6,925 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
NEURODERM LTD | COM | M74231107 | 399 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 5,487 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 4,885 | 2,505,000 | SH | SOLE | 2,505,000 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 15,249 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 9,084 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
TENAX THERAPEUTICS INC | COM | 88032L100 | 2,343 | 635,000 | SH | SOLE | 635,000 | 0 | 0 | ||
TETRAPHASE PHARMACEUTICALS I | COM | 88165N105 | 3,084 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
TONIX PHARMACEUTICALS HLDG C | COM | 890260201 | 1,704 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
TRACON PHARMACEUTICALS INC | COM | 89237H10A | 138 | 12,172 | SH | SOLE | 12,172 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 5,455 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 11,263 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
XOMA CORP DEL | COM | 98419J107 | 2,522 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ZOGENIX INC | COM | 98978L105 | 1,533 | 912,500 | SH | SOLE | 912,500 | 0 | 0 | ||
ZS PHARMA INC | COM | 98979G105 | 4,977 | 95,000 | SH | SOLE | 95,000 | 0 | 0 |